Search research articles
Contact Us
Filters
Showing results (61-70 of 234) with videos related to
Page
of 24
Sort By:
JAMA
|
October 27, 2020
Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes
Eric R Bates
Circulation. Cardiovascular Interventions
|
April 13, 2016
Misguided Use of Multivariable Analysis to Study Primary Percutaneous Coronary Intervention in Patients With Prior Coronary Artery Bypass Graft
Eric R Bates
Annals of Internal Medicine
|
November 20, 2018
Review: In coronary artery disease, PCI reduces 30-day and 5-year risk for stroke compared with CABG
Eric R Bates
Annals of Internal Medicine
|
March 1, 2021
In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes
Eric R Bates
American Journal of Therapeutics
|
February 1, 1995
Primary Angioplasty Is the Optimal Approach to Early Reperfusion in Patients with Acute Myocardial Infarction
Eric R. Bates
Heart (British Cardiac Society)
|
March 12, 2013
Multivessel coronary artery disease revascularisation strategies in patients with diabetes mellitus
Eric R Bates
ACP Journal Club
|
March 5, 2002
Review: platelet glycoprotein IIb/IIIa blockers for PCI or acute coronary syndromes reduce death and MI but increase bleeding
Eric R Bates
ACP Journal Club
|
September 5, 2003
Both invasive and optimized medical therapies improved quality of life in angina but invasive therapy had fewer major adverse cardiac events
Eric R Bates
Annals of Internal Medicine
|
February 28, 2017
In left main CAD, CABG reduced major adverse cardiac or cerebrovascular events at 5 years compared with PCI
Eric R Bates
Annals of Internal Medicine
|
July 21, 2015
ACP Journal Club. Review: After coronary DES placement, ≤ 6 mo and 1 y of dual-antiplatelet therapy do not differ for cardiac events
Eric R Bates
Page
of 24
Search research articles
Search
Showing results (61-70 of 234) with videos related to
Sort By:
Page
of 24
JAMA
|
October 27, 2020
Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes
Eric R Bates
Circulation. Cardiovascular Interventions
|
April 13, 2016
Misguided Use of Multivariable Analysis to Study Primary Percutaneous Coronary Intervention in Patients With Prior Coronary Artery Bypass Graft
Eric R Bates
Annals of Internal Medicine
|
November 20, 2018
Review: In coronary artery disease, PCI reduces 30-day and 5-year risk for stroke compared with CABG
Eric R Bates
Annals of Internal Medicine
|
March 1, 2021
In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes
Eric R Bates
American Journal of Therapeutics
|
February 1, 1995
Primary Angioplasty Is the Optimal Approach to Early Reperfusion in Patients with Acute Myocardial Infarction
Eric R. Bates
Heart (British Cardiac Society)
|
March 12, 2013
Multivessel coronary artery disease revascularisation strategies in patients with diabetes mellitus
Eric R Bates
ACP Journal Club
|
March 5, 2002
Review: platelet glycoprotein IIb/IIIa blockers for PCI or acute coronary syndromes reduce death and MI but increase bleeding
Eric R Bates
ACP Journal Club
|
September 5, 2003
Both invasive and optimized medical therapies improved quality of life in angina but invasive therapy had fewer major adverse cardiac events
Eric R Bates
Annals of Internal Medicine
|
February 28, 2017
In left main CAD, CABG reduced major adverse cardiac or cerebrovascular events at 5 years compared with PCI
Eric R Bates
Annals of Internal Medicine
|
July 21, 2015
ACP Journal Club. Review: After coronary DES placement, ≤ 6 mo and 1 y of dual-antiplatelet therapy do not differ for cardiac events
Eric R Bates
Page
of 24